MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism

Doxorubicin (DOX) is one of the most commonly used anticancer drugs in the treatment of hepatoma. However, acquired drug resistance is one of the major challenges for the chemotherapy. In this study, a down-regulation of miR-122 was observed in doxorubicin-resistant Huh7 (Huh7/R) cells compared with...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Chenwei, Wang, Xiaodong, Shi, Keqing, Zheng, Yi, Li, Jie, Chen, Yongping, Jin, Lingxiang, Pan, Zhenzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854441/
https://www.ncbi.nlm.nih.gov/pubmed/27138141
http://dx.doi.org/10.1371/journal.pone.0152090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854441/
https://www.ncbi.nlm.nih.gov/pubmed/27138141
http://dx.doi.org/10.1371/journal.pone.0152090

Ejemplares similares